🧫
Monoclonal antibody half-life and protection study
active
experiment
Created: 2026-04-10T03:39:55
By: experiment_extractor
Quality:
90%
✓ SciDEX
ID: experiment-exp-1105fe71-5dd5-4129-a4df-3
🧫 Experiment Protocol
Animal Modelproposed
Related Entities
▸Metadata
| _origin | {'url': None, 'type': 'internal', 'tracked_at': '2026-04-10T03:39:55.447908'} |
| p_value | None |
| protocol | Administration of monoclonal antibodies (wild-type vs half-life-extended) to TKI mice followed by SARS-CoV-2 Omicron BA.2 challenge and assessment of lung viral loads |
| effect_size | None |
| sample_size | None |
| source_pmid | 40020261 |
| extracted_at | 2026-04-09T20:39:55.416847 |
| _schema_version | 1 |
| experiment_type | animal_model |
| success_criteria | Significant reduction in lung viral loads with half-life-extended antibody treatment |
| expected_outcomes | Half-life-extended antibody should show prolonged circulation and better protection compared to wild-type antibody |
| statistical_methods | None |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
10%
Debates
0
Incoming
2
Outgoing
3
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.